Username Password
S&P 500: 1,351.68 Change: +0.14%

HUMAN GENOME SCIENCES INC (HGSI)

Overview
Price 0.00
Price Change Today 0.00 (0.00%)
P&P rating Rating: 1
Zacks Rank 3 - HOLD
Open Price $0.00
Previous Close $0.00
Daily Range $0.00 - $0.00
52-Week Range $6.51 - $30.15
Volume 0
chart
Human Genome Sciences is a biopharmaceutical company with a pipeline of novel compounds in clinical development, including drugs to treat such diseases as hepatitis C, lupus, anthrax disease, cancer, rheumatoid arthritis and HIV/AIDS. Additional products are in clinical development by companies with which we are collaborating. Its mission is to discover, develop, manufacture and market innovative drugs that serve patients with unmet medical needs, with a primary focus on protein and antibody products.
Other Resources for HGSI
zacks.com
Commentary
Zacks Blog: Benlysta Sales Expected to Improve
January 10, 2012
Zacks Blog: Zacks Industry Outlook Highlights: Vertex Pharma, Human Genome Sciences, Biogen Idec and Perrigo
December 29, 2011
Zacks Blog: Glaxo/HGSI Initiate New Study
December 19, 2011
Zacks Blog: Human Genome Upped to Neutral
December 9, 2011
Zacks Blog: Zacks Sell List Highlights: RadioShack, Human Genome Sciences, International Speedway and Live Nation Entertainment
November 17, 2011
Human Genome Sciences is a biopharmaceutical company with a pipeline of novel compounds in clinical development, including drugs to treat such diseases as hepatitis C, lupus, anthrax disease, cancer, rheumatoid arthritis and HIV/AIDS. Additional products are in clinical development by companies with which we are collaborating. Its mission is to discover, develop, manufacture and market innovative drugs that serve patients with unmet medical needs, with a primary focus on protein and antibody products.
 
Brokerage Analyst Recommendations
15 Brokerage Firms Covering HGSI
 
    
Strong Buy
8
Buy
1
Hold
5
Sell
1
Strong Sell
0
Average Broker Recommendation (ABR): 1.93
 
HGSI Ratings:BUY  SELL  HOLD
HGSI Consensus Forecasts
Rate this Stock!
You haven't rated this stock yet!

What The Community Thinks

Total Players

20 Buy
5 Sell
 
Top Buy Analysis
BUY: HGSI Rating: 1
Company: HUMAN GENOME SCIENCES INC.
Points: -77.01
Start Price: $25.32
Start Date: 05/13/2010 11:25 PM
wishbone
wishbone
P&P Score: 0.79
Recs:
good pipeline

Comments: 0 | Comment


Top Sell Analysis
SELL: HGSI Rating: 1
Company: HUMAN GENOME SCIENCES INC.
Points: 87.13
Start Price: $28.16
Start Date: 12/03/2009 10:29 PM
BearNekkid
BearNekkid
P&P Score: 0.48
Recs:

Comments: 0 | Comment

Blog Posts
User User Score Date Title Comments Last Comment
rjm77me
99.92 07/02/10 Insiders buy and sellers 2 07/06/10
AndrewGreenBull
97.65 03/15/10 PDEX:Small Cap, Big Potential 0
AndrewGreenBull
97.65 12/01/09 DARA--Will It be the No.11? 0
zantriocom
0.00 12/01/09 Zantrio.com Free Daily Stock Picks 12-1-09 0
Zacks_Analysts
0.00 01/10/12 Benlysta Sales Expected to Improve - Analyst Blog 0
Zacks_Analysts
0.00 12/19/11 Glaxo/HGSI Initiate New Study - Analyst Blog 0
Zacks_Analysts
0.00 12/09/11 Human Genome Upped to Neutral - Analyst Blog 0
Zacks_Analysts
0.00 11/02/11 Human Genome Downgraded - Analyst Blog 0
Zacks_Analysts
0.00 10/27/11 Weak Benlysta Sales Hurt Human Genome - Analyst Blog 0
Zacks_Analysts
0.00 08/19/11 Human Genome Evenly Poised - Analyst Blog 0
Pages: [ 1 ]  2   3   4   5   6  >>
Commentary
BUY: HUMAN GENOME SCIENCES INC. (HGSI) Rating: 1
Start Price: $25.32
Points: -77.01
Created: 05/13/2010
good pipeline

Comments: 0 | Comment

Recs:
 
BUY: HUMAN GENOME SCIENCES INC. (HGSI) Rating: 1
Start Price: $2.66
Points: +231.39
Created: 06/18/2009
Phase III results on Lupus in July and a Phase III in November with GSK in November

Comments: 0 | Comment

Recs:
 
BUY: HUMAN GENOME SCIENCES INC. (HGSI) Rating: 1
Start Price: $2.73
Points: +224.94
Created: 06/06/2009
Huge growth potential based on the portfolio of drugs it is developing and its recent favorable news concerning its license application for FDA approval of ABthrax.

Comments: 0 | Comment

Recs:
 
SELL: HUMAN GENOME SCIENCES INC. (HGSI) Rating: 1
Start Price: $28.16
Points: +87.13
Created: 12/03/2009

Comments: 0 | Comment

Recs:
 
BUY: HUMAN GENOME SCIENCES INC. (HGSI) Rating: 1
Start Price: $10.08
Points: +7.82
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: HUMAN GENOME SCIENCES INC. (HGSI) Rating: 1
Start Price: $8.97
Points: +20.18
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: HUMAN GENOME SCIENCES INC. (HGSI) Rating: 1
Start Price: $11.45
Points: -4.13
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: HUMAN GENOME SCIENCES INC. (HGSI) Rating: 1
Start Price: $10.14
Points: +7.23
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: HUMAN GENOME SCIENCES INC. (HGSI) Rating: 1
Start Price: $11.89
Points: -7.39
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
SELL: HUMAN GENOME SCIENCES INC. (HGSI) Rating: 1
Start Price: $10.34
Points: -5.31
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
Pages: [ 1 ]  2   3  >>
Picks
Username P&P Score Call Time Frame Start Date Start Price Today (change) Stock Gain S&P Gain Points Analysis
wishbone 0.79 BUY Six Months to a Year 05/13/2010 $25.32 $10.07
(+1.82%)
-60.23% +16.78% -77.01 view
BearNekkid 0.48 SELL Three to Six Months 12/03/2009 $28.16 $10.07
(+1.82%)
-64.24% +22.89% +87.13
quinn5 BUY Three to Six Months 06/18/2009 $2.66 $10.07
(+1.82%)
+278.57% +47.18% +231.39 view
Speak2MeEZ BUY Six Months to a Year 06/06/2009 $2.73 $10.07
(+1.82%)
+268.86% +43.93% +224.94 view
Elroy 75.80 BUY Six Months to a Year 01/01/2008 $10.08 $10.07
(+1.82%)
-0.10% -7.92% +7.82
maceace 32.63 BUY Six Months to a Year 01/01/2008 $8.97 $10.07
(+1.82%)
+12.26% -7.92% +20.18
Schuh 53.45 BUY Six Months to a Year 01/01/2008 $11.45 $10.07
(+1.82%)
-12.05% -7.92% -4.13
Elkman1 BUY Six Months to a Year 01/01/2008 $10.14 $10.07
(+1.82%)
-0.69% -7.92% +7.23
Borland 0.81 BUY Six Months to a Year 01/01/2008 $11.89 $10.07
(+1.82%)
-15.31% -7.92% -7.39
shiningb 27.88 SELL Six Months to a Year 01/01/2008 $10.34 $10.07
(+1.82%)
-2.61% -7.92% -5.31
Pages: [ 1 ]  2   3  >>
Sponsored Links